Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19

Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19

Background: Glucocorticoid therapy has emerged as an effective therapeutic option in hospitalized patients with coronavirus disease 2019 (COVID-19). This study aimed to focus on the impact of relevant clinical and laboratory factors on the protective effect of glucocorticoids on mortality. Methods:...

Full description

Bibliographic Details
Main Authors: Matteo Pagnesi, Riccardo M. Inciardi, Carlo M. Lombardi, Piergiuseppe Agostoni, Pietro Ameri, Lucia Barbieri, Antonio Bellasi, Rita Camporotondo, Claudia Canale, Valentina Carubelli, Stefano Carugo, Francesco Catagnano, Laura A. Dalla Vecchia, Gian Battista Danzi, Mattia Di Pasquale, Margherita Gaudenzi, Stefano Giovinazzo, Massimiliano Gnecchi, Marco Guazzi, Annamaria Iorio, Maria Teresa La Rovere, Sergio Leonardi, Gloria Maccagni, Massimo Mapelli, Davide Margonato, Marco Merlo, Luca Monzo, Andrea Mortara, Vincenzo Nuzzi, Massimo Piepoli, Italo Porto, Andrea Pozzi, Filippo Sarullo, Gianfranco Sinagra, Chiara Tedino, Daniela Tomasoni, Maurizio Volterrani, Gregorio Zaccone, Michele Senni, Marco Metra
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
Glucocorticoid
Corticosteroid
Steroid
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221004586

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221004586

Similar Items